AI Designs New Antibiotics to Fight Superbugs | JQJO

Researchers at MIT have used artificial intelligence to design two potential new antibiotics targeting drug-resistant gonorrhea and MRSA. The AI designed the drugs atom-by-atom, successfully killing the superbugs in lab and animal tests. While years of refinement and clinical trials are needed before human use, the team believes this marks a significant advancement in antibiotic discovery, potentially launching a "second golden age" in the field. The study, published in Cell, involved training AI on millions of compounds to predict effective molecular structures, ultimately yielding two promising drug candidates.